Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Steven Edward Lenicek is active.

Publication


Featured researches published by Steven Edward Lenicek.


Journal of Medicinal Chemistry | 2008

Advances toward New Antidepressants with Dual Serotonin Transporter and 5-HT1A Receptor Affinity within a Class of 3-Aminochroman Derivatives. Part 2

Nicole T. Hatzenbuhler; Reinhardt Bernhard Baudy; Deborah Ann Evrard; Amedeo Arturo Failli; Boyd L. Harrison; Steven Edward Lenicek; Richard Eric Mewshaw; Annmarie Saab; Uresh Shantilal Shah; Jean Sze; Minsheng Zhang; Dahui Zhou; Michael Chlenov; Michael Z. Kagan; Jeannette Golembieski; Geoffrey Hornby; Margaret Lai; Deborah L. Smith; Kelly Sullivan; Lee E. Schechter; Terrance H. Andree

Novel compounds combining a 5-HT 1A moiety (3-aminochroman scaffold) and a 5-HT transporter (indole analogues) linked through a common basic nitrogen via an alkyl chain attached at the 1- or 3-position of the indole were evaluated for dual affinity at both the 5-HT reuptake site and the 5-HT 1A receptor. Compounds of most interest were found to have a 5-carbamoyl-8-fluoro-3-amino-3,4-dihydro-2 H-1-benzopyran linked to a 3-alkylindole (straight chain), more specifically substituted with a 5-fluoro (( R)-(-)- 35c), 5-cyano ((-)- 52a), or 5,7-difluoro ((-)- 52g). Several factors contributed to 5-HT 1A affinity, serotonin rat transporter affinity, and functional antagonism in vitro. Although most of our analogues showed good to excellent affinities at both targets, specific features such as cyclobutyl substitution on the basic nitrogen and stereochemistry at the 3-position of the chroman moiety seemed necessary for antagonism at the 5-HT 1A receptor. Branched linkers seemed to impart antagonism even as racemates; however, the potency of these analogues in the functional assay was not desirable enough to further pursue these compounds.


Bioorganic & Medicinal Chemistry | 2009

Novel 1-aminoethyl-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines are potent 5-HT6 agonists

Ronald C. Bernotas; Steven Edward Lenicek; Schuyler Adam Antane; Derek Cecil Cole; Boyd L. Harrison; Albert J. Robichaud; Guo Ming Zhang; Deborah L. Smith; Brian Platt; Qian Lin; Ping Li; Joseph Coupet; Sharon Rosenzweig-Lipson; Chad E. Beyer; Lee E. Schechter

A series of 1-aminoethyl-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines 10a-z was prepared as novel 5-HT(6) ligands. The best compounds were high affinity, full agonists at 5-HT(6) receptors. Several agonists demonstrated good selectivity over other serotonergic and dopaminergic receptors. Acute administration of selective agonist 10e significantly increased extracellular GABA concentrations in rat frontal cortex. This compound also reduced adjunctive drinking behavior in the rat schedule-induced polydipsia assay, possibly predictive of efficacy in obsessive compulsive disorder and other anxiety related disorders.


Bioorganic & Medicinal Chemistry Letters | 2009

1-(2-Aminoethyl)-3-(arylsulfonyl)-1H-pyrrolopyridines are 5-HT6 receptor ligands

Ronald C. Bernotas; Schuyler Adam Antane; Steven Edward Lenicek; Simon N. Haydar; Albert J. Robichaud; Boyd L. Harrison; Guo Ming Zhang; Deborah L. Smith; Joseph Coupet; Lee E. Schechter

1-(2-Aminoethyl)-3-(arylsulfonyl)-1H-pyrrolopyridines were prepared. Binding assays indicated they are 5-HT(6) receptor ligands, among which 6f and 6g showed high affinity for 5-HT(6) receptors with K(i)=3.9 and 1.7 nM, respectively.


Archive | 2003

1-Heterocyclylalkyl-3-sulfonylindole or -indazole derivatives as 5-hydroxytryptamine-6 ligands

Ronald C. Bernotas; Steven Edward Lenicek


Archive | 2003

1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands

Ronald C. Bernotas; Steven Edward Lenicek; Schuyler Adam Antane


Bioorganic & Medicinal Chemistry Letters | 2004

1-(2-Aminoethyl)-3-(arylsulfonyl)-1H-indoles as novel 5-HT6 receptor ligands.

Ronald C. Bernotas; Steven Edward Lenicek; Schuyler Adam Antane; Guo Ming Zhang; Deborah L. Smith; Joseph Coupet; Boyd L. Harrison; Lee E. Schechter


Archive | 2004

3-amino chroman and 2-amino tetralin derivatives

Nicole T. Hatzenbuhler; Deborah Ann Evrard; Richard Eric Mewshaw; Dahui Zhou; Uresh Shantilal Shah; Jennifer Ann Inghrim; Steven Edward Lenicek; Reinhardt Bernhard Baudy; John A. Butera; Annmarie Louise Sabb; Amedeo Arturo Failli; Pudukkaraipudur Sivaramakrishnan Ramamoorthy


Archive | 2003

1-(aminoalkyl)-3-sulfonylindole and-indazole derivatives as 5-hydroxytryptamine-6 ligands

Ronald C. Bernotas; Steven Edward Lenicek; Schuyler Adam Antane; Ping Zhou; Yanfang Li


Journal of Liquid Chromatography & Related Technologies | 2006

High Speed Preparative HPLC Separation of Regioisomers of a Pharmaceutical Intermediate Using Gradients of Methanol in Ethoxynonafluorobutane

Michael Z. Kagan; Steven Edward Lenicek; R. Bernotas


Archive | 2006

DERIVADOS DE 3-AMINO CROMAN Y 2-AMINO TETRALIN

Nicole T. Hatzenbuhler; Deborah Ann Evrard; Richard Eric Mewshaw; Dahui Zhou; Uresh Shantilal Shah; Jennifer Ann Inghrim; Steven Edward Lenicek; Reinhardt Bernhard Baudy; John A. Butera; Annmarie Louise Sabb; Amedeo Arturo Failli; Pudukkaraipudur Sivaramakrishnan Ramamoorthy

Collaboration


Dive into the Steven Edward Lenicek's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge